Search Results

There are 3242 results for: content related to: Final 5-year results of Z-FAST trial

  1. You have free access to this content
    Increases in bone turnover marker levels at an early phase after starting zoledronic acid predicts skeletal-related events in patients with prostate cancer with bone metastasis

    BJU International

    Volume 109, Issue 3, February 2012, Pages: 394–400, Kouji Izumi, Atsushi Mizokami, Shingo Itai, Takashi Shima, Kazuyoshi Shigehara, Sotaro Miwa, Yuji Maeda, Hiroyuki Konaka, Eitetsu Koh and Mikio Namiki

    Version of Record online : 23 MAY 2011, DOI: 10.1111/j.1464-410X.2011.10192.x

  2. Influence of Zoledronic Acid on Atrial Electrophysiological Parameters and Electrocardiographic Measurements

    Journal of Cardiovascular Electrophysiology

    Volume 26, Issue 6, June 2015, Pages: 671–677, JAMES E. TISDALE, MATTHEW R. ALLEN, BRIAN R. OVERHOLSER, HEATHER A. JAYNES and RICHARD J. KOVACS

    Version of Record online : 31 MAR 2015, DOI: 10.1111/jce.12641

  3. The Pharmacokinetics and Pharmacodynamics of Zoledronic Acid in Cancer Patients with Varying Degrees of Renal Function

    The Journal of Clinical Pharmacology

    Volume 43, Issue 2, February 2003, Pages: 154–162, Dr. Andrej Skerjanec, Dr. James Berenson, Dr. ChyiHung Hsu, Dr. Pierre Major, Dr. Wilson H. Miller Jr., Ms. Christina Ravera, Dr. Horst Schran, Dr. John Seaman and Dr. Felix Waldmeier

    Version of Record online : 8 MAR 2013, DOI: 10.1177/0091270002239824

  4. Docetaxel/zoledronic acid combination triggers apoptosis synergistically through downregulating antiapoptotic Bcl-2 protein level in hormone-refractory prostate cancer cells

    Cell Biology International

    Volume 33, Issue 2, February 2009, Pages: 239–246, B. Karabulut, C. Erten, M.K. Gul, E. Cengiz, B. Karaca, Y. Kucukzeybek, G. Gorumlu, H. Atmaca, S. Uzunoglu, U.A. Sanli, Y. Baran and R. Uslu

    Version of Record online : 2 JAN 2013, DOI: 10.1016/j.cellbi.2008.11.011

  5. Denosumab for the Prevention of Skeletal-Related Events in Patients with Bone Metastasis from Solid Tumor

    Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

    Volume 32, Issue 3, March 2012, Pages: 274–284, Maryam Iranikhah, Teresa W. Wilborn, Terri M. Wensel and Jodi B. Ferrell

    Version of Record online : 13 FEB 2012, DOI: 10.1002/j.1875-9114.2011.01092.x

  6. You have free access to this content
    A single infusion of zoledronic acid produces sustained remissions in paget disease: Data to 6.5 years

    Journal of Bone and Mineral Research

    Volume 26, Issue 9, September 2011, Pages: 2261–2270, Ian R Reid, Kenneth Lyles, Guoqin Su, Jacques P Brown, John P Walsh, Javier del Pino-Montes, Paul D Miller, William D Fraser, Susan Cafoncelli, Christina Bucci-Rechtweg and David J Hosking

    Version of Record online : 19 AUG 2011, DOI: 10.1002/jbmr.438

  7. Denosumab for the Treatment of Osteoporosis and Cancer-Related Conditions

    Clinical Pharmacology & Therapeutics

    Volume 91, Issue 1, January 2012, Pages: 123–133, E M Lewiecki and J P Bilezikian

    Version of Record online : 7 DEC 2011, DOI: 10.1038/clpt.2011.268

  8. Bisphosphonates and other bone agents for breast cancer

    Intervention Review

    The Cochrane Library

    Matthew HF Wong, Martin R Stockler and Nick Pavlakis

    Published Online : 15 FEB 2012, DOI: 10.1002/14651858.CD003474.pub3

  9. You have free access to this content
    Once-yearly zoledronic acid and days of disability, bed rest, and back pain: Randomized, controlled HORIZON Pivotal Fracture Trial

    Journal of Bone and Mineral Research

    Volume 26, Issue 5, May 2011, Pages: 984–992, Jane A Cauley, Dennis Black, Steven Boonen, Steven R Cummings, Peter Mesenbrink, Lisa Palermo, Zulema Man, Peyman Hadji, Ian R Reid and on behalf of the HORIZON Pivotal Fracture Group

    Version of Record online : 3 MAY 2011, DOI: 10.1002/jbmr.292

  10. You have free access to this content
    Effects of intravenous zoledronic acid plus subcutaneous teriparatide [rhPTH(1–34)] in postmenopausal osteoporosis

    Journal of Bone and Mineral Research

    Volume 26, Issue 3, March 2011, Pages: 503–511, Felicia Cosman, Erik Fink Eriksen, Chris Recknor, Paul D Miller, Núria Guañabens, Christian Kasperk, Philemon Papanastasiou, Aimee Readie, Hanumantha Rao, Jürg A Gasser, Christina Bucci-Rechtweg and Steven Boonen

    Version of Record online : 18 FEB 2011, DOI: 10.1002/jbmr.238

  11. The use of zoledronic acid in pediatric cancer patients

    Pediatric Blood & Cancer

    Volume 56, Issue 4, April 2011, Pages: 610–614, Keith J. August, Amanda Dalton, Howard M. Katzenstein, Bradley George, Thomas A. Olson, Karen Wasilewski-Masker and Louis B. Rapkin

    Version of Record online : 23 DEC 2010, DOI: 10.1002/pbc.22681

  12. Exposing human epithelial cells to zoledronic acid can mediate osteonecrosis of jaw: an in vitro model

    Journal of Oral Pathology & Medicine

    Volume 41, Issue 10, November 2012, Pages: 788–792, S. Saracino, R. A. Canuto, M. Maggiora, M. Oraldi, M. Scoletta, L. Ciuffreda, A. M. Vandone, S. Carossa, M. Mozzati and G. Muzio

    Version of Record online : 31 MAY 2012, DOI: 10.1111/j.1600-0714.2012.01173.x

  13. You have free access to this content
    Retrospective analysis of antitumor effects of zoledronic acid in breast cancer patients with bone-only metastases

    Cancer

    Volume 118, Issue 8, 15 April 2012, Pages: 2039–2047, Naoki Niikura, Jun Liu, Naoki Hayashi, Shana L. Palla, Yutaka Tokuda, Gabriel N. Hortobagyi, Naoto T. Ueno and Richard L. Theriault

    Version of Record online : 2 DEC 2011, DOI: 10.1002/cncr.26512

  14. You have free access to this content
    Pain outcomes in patients with advanced breast cancer and bone metastases

    Cancer

    Volume 119, Issue 4, 15 February 2013, Pages: 832–838, Charles S. Cleeland, Jean-Jacques Body, Alison Stopeck, Roger von Moos, Lesley Fallowfield, Susan D. Mathias, Donald L. Patrick, Mark Clemons, Katia Tonkin, Norikazu Masuda, Allan Lipton, Richard de Boer, Stefania Salvagni, Celia Tosello Oliveira, Yi Qian, Qi Jiang, Roger Dansey, Ada Braun and Karen Chung

    Version of Record online : 5 SEP 2012, DOI: 10.1002/cncr.27789

  15. Zoledronic acid for the treatment of osteopenia in pediatric Crohn's disease

    Pediatrics International

    Volume 52, Issue 5, October 2010, Pages: 754–761, Anne Marie Sbrocchi, Sylviane Forget, Diane Laforte, E. Michel Azouz and Celia Rodd

    Version of Record online : 26 MAY 2010, DOI: 10.1111/j.1442-200X.2010.03174.x

  16. Comparison of effects of clodronate and zoledronic acid on the repair of maxilla surgical wounds – histomorphometric, receptor activator of nuclear factor-kB ligand, osteoprotegerin, von Willebrand factor, and caspase-3 evaluation

    Journal of Oral Pathology & Medicine

    Volume 41, Issue 9, October 2012, Pages: 702–712, Ana C. U. Vasconcelos, Soraya A. Berti-Couto, Alan A. Azambuja, Fernanda G. Salum, Maria A. Figueiredo, Vinícius D. da Silva and Karen Cherubini

    Version of Record online : 14 MAR 2012, DOI: 10.1111/j.1600-0714.2012.01140.x

  17. You have full text access to this OnlineOpen article
    Phase II study of zoledronic acid combined with docetaxel for non-small-cell lung cancer: West Japan Oncology Group

    Cancer Science

    Volume 105, Issue 8, August 2014, Pages: 989–995, Haruyasu Murakami, Takeharu Yamanaka, Takashi Seto, Kenji Sugio, Isamu Okamoto, Toshiyuki Sawa, Tomonori Hirashima, Koji Takeda, Shinji Atagi, Masahiro Fukuoka, Yoichi Nakanishi, Kazuhiko Nakagawa and Nobuyuki Yamamoto

    Version of Record online : 12 JUL 2014, DOI: 10.1111/cas.12448

  18. The use of bisphosphonates in cancer treatment

    Annals of the New York Academy of Sciences

    Volume 1218, Issue 1, February 2011, Pages: 3–14, Robert Coleman

    Version of Record online : 28 SEP 2010, DOI: 10.1111/j.1749-6632.2010.05766.x

  19. You have free access to this content
    Differing effects of PTH 1–34, PTH 1–84, and zoledronic acid on bone microarchitecture and estimated strength in postmenopausal women with osteoporosis: An 18-month open-labeled observational study using HR-pQCT

    Journal of Bone and Mineral Research

    Volume 28, Issue 4, April 2013, Pages: 736–745, Stinus Hansen, Ellen M Hauge, Jens-Erik Beck Jensen and Kim Brixen

    Version of Record online : 18 MAR 2013, DOI: 10.1002/jbmr.1784

  20. Zoledronic acid and irradiation in oral squamous cell carcinoma

    Journal of Oral Pathology & Medicine

    Volume 44, Issue 2, February 2015, Pages: 103–108, Pia Lopez Jornet, Sanchez Carrillo Susana, Tudela Mulero Rosario and Pons-Fuster Alvaro

    Version of Record online : 24 JUL 2014, DOI: 10.1111/jop.12205